CWA
EBS icon

Clarus Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

Clarus Wealth Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,114
Closed -$102K – 243
2019
Q2 		$102K Buy
2,114
+496
+31% +$23.8K 0.07% 186
2019
Q1 		$82K Hold
1,618
– – 0.06% 222
2018
Q4 		$96K Buy
1,618
+1,518
+1,518% +$97.9K 0.15% 170
2018
Q3 		$7K Sell
100
-200
-67% -$11.7K ﹤0.01% 581
2018
Q2 		$16K Buy
+300
New +$15.6K 0.01% 453

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Clarus Wealth Advisors's EBS Position: Q3 2019 in Review

Clarus Wealth Advisors sold out of Emergent Biosolutions (EBS) in Q3 2019, closing a stake of 2,114 shares — an estimated $102K sold.

Clarus Wealth Advisors first reported a position in EBS in Q2 2018 and held it in 5 quarters. The position peaked at $102K in Q2 2019. 244 funds tracked by Wall St. Rank hold EBS as of Q3 2019.

  • Clarus Wealth Advisors reported no remaining Emergent Biosolutions position as of Q3 2019 after selling out during the quarter.
  • Clarus Wealth Advisors sold 2,114 Emergent Biosolutions shares in Q3 2019, an estimated $102K.
  • Clarus Wealth Advisors first reported a position in Emergent Biosolutions in Q2 2018 and held it in 5 quarters.
  • Clarus Wealth Advisors's Emergent Biosolutions position peaked at $102K in Q2 2019.
  • 244 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2019.

Based on Clarus Wealth Advisors's 13F filing for Q3 2019, filed 11 Oct 2019.